Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani, et al.
Open Biology (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 94

Showing 26-50 of 94 citing articles:

Study on the mechanism of MDSC-platelets and their role in the breast cancer microenvironment
Xinpu Han, Xiaotong Song, Z. G. Xiao, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Investigating the clinical significance of immune and thyroid biomarkers in women with breast cancer and Hashimoto's thyroiditis
Abdullah Hasan Jabbar, Noori M. Luaibi, Sajid N. Abdul-Qader
Reproductive Biology (2025) Vol. 25, Iss. 2, pp. 101011-101011
Closed Access
Recruitment of Polymorphonuclear Myeloid-Derived Suppressor Cells During Cryptococcus neoformans Infection
Joyce Cristina Guimarães-de-Oliveira, Israel Diniz-Lima, Idália Maria Ferreira-dos-Santos, et al.
Anais da Academia Brasileira de Ciências (2025) Vol. 97, Iss. 2
Open Access
Upregulation of the Renin–Angiotensin System Pathways and SARS-CoV-2 Infection: The Rationale for the Administration of Zinc-Chelating Agents in COVID-19 Patients
Loris Zamai
Cells (2021) Vol. 10, Iss. 3, pp. 506-506
Open Access | Times Cited: 24
Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression
Jianan Cheng, Yixiao Yuan, Bo Zhu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 23
Role of myeloid derived suppressor cells in sepsis
M. U. Malavika, S. Sanju, M.R. Poorna, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108452-108452
Closed Access | Times Cited: 18
N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration
Tong Zhao, Jianni Qi, Tiantian Liu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 17
Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
Agnieszka Szczygieł, Katarzyna Węgierek‐Ciura, Anna Wróblewska, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Cancer Biology and Therapeutics: Navigating Recent Advances and Charting Future Directions

Tropical Journal of Natural Product Research (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 9
MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of post-lung transplant injury
Victoria Leroy, Denny Joseph Manual Kollareth, Zhenxiao Tu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Foxp3 + Treg-derived IL-10 promotes colorectal cancer-derived lung metastasis
Ahmad Mustafa Shiri, Mohammad Fard-Aghaie, Tanja Bedke, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
TGF-β inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model
Nourridine Siewe, Avner Friedman
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0252620-e0252620
Open Access | Times Cited: 23
Transforming growth f actor‐beta1 and m yeloid‐derived suppressor cells: A cancerous partnership
Slavko Mojsilović, Sonja S. Mojsilović, Sunčica Kapor, et al.
Developmental Dynamics (2021) Vol. 251, Iss. 1, pp. 85-104
Open Access | Times Cited: 22
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Mariele Montanari, Barbara Canonico, Evelyn Nordi, et al.
Advances in Biological Regulation (2021) Vol. 81, pp. 100820-100820
Open Access | Times Cited: 19
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art
Dorota Suszczyk, Wiktoria Skiba, Joanna Jakubowicz-Gil, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 677-677
Open Access | Times Cited: 18
CMTM6 as a master regulator of PD-L1
Mahmoud Mohammad Yaseen, Nizar Mohammad Abuharfeil, Homa Darmani
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 10, pp. 2325-2340
Open Access | Times Cited: 13
Local administration of myeloid-derived suppressor cells prevents progression of immune-mediated dry eye disease
Pier Luigi Surico, Seok-Joo Lee, Rohan Bir Singh, et al.
Experimental Eye Research (2024) Vol. 242, pp. 109871-109871
Closed Access | Times Cited: 2
The impact of IL‐10 and IL‐17 on myeloid‐derived suppressor cells in vitro and in vivo in a murine model of asthma
Charlotte Vetter, Jakob Schieb, Nora Vedder, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 7
Open Access | Times Cited: 2
Myeloid-Derived Suppressor Cells and Macrophage Polarization in Cancer Immunotherapy
Mohammad‐Salar Hosseini, Mohammad Amin Akbarzadeh, Farhad Jadidi‐Niaragh
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 157-204
Closed Access | Times Cited: 2
Peripheral immune profiling of soft tissue sarcoma: perspectives for disease monitoring
Jani Sofia Almeida, Luana Madalena Sousa, Patrícia Couceiro, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Metal Peroxide Nanoparticles for Modulating the Tumor Microenvironment: Current Status and Recent Prospects
Jagadeesh Rajaram, Yaswanth Kuthati
Cancers (2024) Vol. 16, Iss. 21, pp. 3581-3581
Open Access | Times Cited: 2
Nasal mRNA Nanovaccine with Key Activators of Dendritic and MAIT Cells for Effective Against Lung Tumor Metastasis in Mice Model
Ang Li, Xushan Cai, Dong Li, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 11479-11497
Open Access | Times Cited: 2
Contrasting behavior between the three human monocyte subsets in dengue pathophysiology
Deepti Maheshwari, Keshav Saini, Prabhat Singh, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104384-104384
Open Access | Times Cited: 12
Advances in the study of myeloid-derived suppressor cells in infectious lung diseases
Meng-Nan Zhang, Yu-Lai Yuan, Su-Hua Ao
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6

Scroll to top